MannKind Corp (NASDAQ:MNKD)

4.18
Delayed Data
As of May 23
 +0.49 / +13.32%
Today’s Change
2.49
Today|||52-Week Range
5.53
-4.46%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close3.68
Today’s open3.73
Day’s range3.57 - 4.77
Volume25,427,103
Average volume (3 months)3,652,821
Market cap$929.4M
Data as of 3:59pm ET, 05/23/2022

Growth & Valuation

Earnings growth (last year)-26.24%
Earnings growth (this year)+14.21%
Earnings growth (next 5 years)+30.20%
Revenue growth (last year)+15.81%
P/E ratioNM
Price/Sales14.44
Price/Book--

Competitors

----
ENTAEnanta Pharmaceutica...+0.60+1.43%
RVNCRevance Therapeutics...-0.60-4.36%
KURAKura Oncology Inc+0.16+1.27%
Data as of 4:00pm ET, 05/23/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$75.4M
Annual profit (last year)-$80.9M
Net profit margin-107.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Danbury, Connecticut

Forecasts